Contact: Eric Rozet, Statistician +32 (0) 473 690 914

Slides:



Advertisements
Similar presentations
So how good are your results? (An introduction to quantitative QC)
Advertisements

Quality is a Lousy Idea-
Supplementary material ANALYTICAL METHOD TRANSFER USING EQUIVALENCE TESTS WITH REASONABLE ACCEPTANCE CRITERIA AND APPROPRIATE EFFORT : EXTENSION OF THE.
Parallelism in practice USP Bioassay Workshop August 2010
Mitigating Risk of Out-of-Specification Results During Stability Testing of Biopharmaceutical Products Jeff Gardner Principal Consultant 36 th Annual Midwest.
PHARM 462 PART / /31 Good Manufacturing Practices (GMP) VALIDATION of ANALYTICAL TEST METHODS.
World Health Organization
TOWARDS A RISK BASED METHODOLOGY TO ASSESS THE ACCEPTABILITY OF AN ANALYTICAL METHOD TRANSFER: COMPARISON OF DIFFERENT APPROACHES. E. Rozet 1, W. Dewe²,
Dr Samah Kotb Lecturer of Biochemistry 1 CLS 432 Dr. Samah Kotb Nasr El-deen Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Nasr.
Utilization of Assay Performance Characteristics to Estimate Hemoglobin A 1c Result Reliability A. Woodworth, N. Korpi-Steiner, J.J. Miller, L.V. Rao,
Validation of Analytical Methods
A Statistical Approach to Method Validation and Out of Specification Data.
Equivalence margins to assess parallelism between 4PL curves
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download,
Inter-Laboratory Method Transfer
Validation of analytical methods
QUALITY CONTROL OF PHYSICO-Chemical METHODS Introduction :Validation توثيق المصدوقية.
Kyiv, TRAINING WORKSHOP ON PHARMACEUTICAL QUALITY, GOOD MANUFACTURING PRACTICE & BIOEQUIVALENCE Validation of Analytical Methods Used For Bioequivalence.
QA/QC FOR ENVIRONMENTAL MEASUREMENT
PAT Validation Working Group Process and Analytical Validation Working Group Arthur H. Kibbe, Ph.D. Chair June 13, 2002.
Unit #7 - Basic Quality Control for the Clinical Laboratory
Radiopharmaceutical Production
Biotechnology Final Project Recombinant DNA Gene Cloning.
Quality Assessment 2 Quality Control.
Validation of Analytical Method
WELCOME. UV Spectrophotometric Method Development And Estimation of Bicalutamide in Pharmaceutical Dosage Form.
VALIDATION METHODOLOGY
The following minimum specified ranges should be considered: Drug substance or a finished (drug) product 80 to 120 % of the test concentration Content.
Analysis and Visualization Approaches to Assess UDU Capability Presented at MBSW May 2015 Jeff Hofer, Adam Rauk 1.
Quality WHAT IS QUALITY
A Bayesian Approach to Parallelism Testing in Bioassay
Measurement Uncertainty Information in
Quality Control Lecture 5
Important informations
Laboratory QA/QC An Overview.
TRANSFER OF A MULTIDIMENSIONAL ON-LINE SPE-LC-ECD METHOD FOR THE DETERMINATION OF THREE MAJOR CATECHOLAMINES IN NATIVE HUMAN URINE. E. Rozet 1, R. Morello.
McGraw-Hill/Irwin © 2006 The McGraw-Hill Companies, Inc., All Rights Reserved. 1.
Data Analysis: Quantitative Statements about Instrument and Method Performance.
The USP Performance Test Dissolution Systems Suitability Studies Walter W. Hauck, Ph.D. USP Consultant Presentation to Advisory Committee for Pharmaceutical.
1 Is it potent? Can these results tell me? Statistics for assays Ann Yellowlees PhD Quantics Consulting Limited.
Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Lecturer of Biochemistry 2015 Introduction to Quality Control.
- 1 - Overall procedure of validation Calibration Validation Figure 12.4 Validation, calibration, and prediction (Oberkampf and Barone, 2004 ). Model accuracy.
Validation Validation: A systematic study which ensures that systems, facilities and processes are working adequetly and precisely. Validation is an integral.
Validation Defination Establishing documentary evidence which provides a high degree of assurance that specification process will consistently produce.
Limit of detection, limit of quantification and limit of blank Elvar Theodorsson.
Sample Size Determination
A Bayesian approach to the Comparison of NIR vs HPLC analytical methods in Continuous Manufacturing Process Validation Studies Areti Manola1, Jyh-Ming.
LECTURE 13 QUALITY ASSURANCE METHOD VALIDATION
 Remember Chemistry panel Quality Control:-  In a medical laboratory, it is a statistical process used to monitor and evaluate the analytical process.
 Routine viral diagnostics: indirect and direct detection of viruses. ◦ Indirect detection: serological tests; ◦ Direct detection:  Viral antigens;
Bioassay Optimization and Robustness Using Design of Experiments Methodology 2015 NBC, San Francisco June 8, 2015 Kevin Guo.
Implementing principles of Quality by Design (QbD) in validation context Cédric Hubert a, Pierre Lebrun a,b, Eric Rozet a,b and Philippe Hubert a a Laboratory.
SEMINAR ON PRESENTED BY BRAHMABHATT BANSARI K. M. PHARM PART DEPARTMENT OF PHARMACEUTICS AND PHARMACEUTICAL TECHNOLGY L. M. COLLEGE OF PHARMACY.
Diagnostic clinical chemistry
Custom peptide synthesis services In the quantitative proteomics research, several MS-based methodologies for relative quantification have been introduced.
Meiyu Shen, Lixin Xu Center for Drug Evaluation and Research,
Meiyu Shen, Lixin Xu Center for Drug Evaluation and Research,
Quality is a Lousy Idea-
World Health Organization
Uncontrolled variation is the enemy of quality
Practical clinical chemistry
Quality is a Lousy Idea-
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download,
Chapter 1: The Nature of Analytical Chemistry
Establishment of acceptance criteria for comparability studies.
ANALYTICAL METHOD VALIDATION
Quality Control Lecture 3
CS639: Data Management for Data Science
Quality Assessment The goal of laboratory analysis is to provide the accurate, reliable and timeliness result Quality assurance The overall program that.
The samples and the Error
Presentation transcript:

Contact: Eric Rozet, Statistician +32 (0)

Transfer of analytical methods: the Bayesian way June 12 th 2014, Bayes 2014, London E. Rozet, P. Lebrun, B. Boulanger

3 Analytical Methods Concentration (X) = ? signal = y concentration signal concentration signal y x No direct quantification ! Needs calibration…: … to obtain concentration (X):

4 Analytical Method Life Cycle Development Validation Routine Use Selection Life Cycle Routine use Routine Use Method Transfer Guarantees ? Reliability ? Validation Sending lab Receiving lab

5 Analytical Method Life Cycle What is the final aim of quantitative analytical methods ?  Start with the end !  Objective: provide results used to make decisions Release of a batch Stability/Shelf life Patient health PK/PD studies, … What matters are the results produced by the method. Fit for purpose means: make correct decisions

6 Analytical Method Life Cycle Need to demonstrate/guarantee that the analytical method will provide, in its future routine use, quality results in order to make correct decisions This is the key aim of Analytical Method Transfer ! How ?

Analytical Method Transfer strategies : Transfer of analytical procedures 1.Co-validation 2.(Re)-validation 3.Transfer Waiver 4.Comparative testing Comparative testing:  Samples taken from the same produced batch are analyzed at the two laboratories  Usually not a paired analysis due to the destructive nature of assays  Assumes sending lab is the reference 7

Comparative testing: decision methodologies 4 methodologies have been proposed: 1.Descriptive: point estimates only 2.Difference: using bilateral Student t-test 3.Equivalence: using confidence intervals of the parameters 4.Total Error: using statistical tolerance intervals (β-expectation tolerance intervals) None are fully « fit for purpose » demonstrations:  Ensure at the end of AMT to make correct decisions (e.g. batch release)

Comparative testing: new proposition The aim of AMT is to ensure that the receiving lab and sending lab will make the same decisions using the analytical results with « high » probability.

Comparative testing: new proposition Proba to be compliant in the 2 labs Proba to be non compliant in the 2 labs Proba to make the same decision in the 2 labs

Comparative testing: common design Batch A Sending Lab Run 1 Rep1 Rep 2 … Run 2 Rep 1 Rep 2 … … Rep 1 Rep 2 … Receiving Lab Run 1 Rep 1 Rep 2 … Run 2 Rep 1 Rep 2 Rep 3 … Rep 1 Rep 2 …

12 Comparative testing: common model

13 Case 1: Content HPLC assay Transfer between two QC labs of an HPLC assay to quantify an active substance in a drug product  Data taken from: Dewé et al., Using total error as decision criterion in analytical method transfer, Chemom. Intel. Lab. Syst. 85 (2007) 262–268.  Design: 1 batch Sender: 1 run 6 replicates Receiver: 3 runs, 6 replicates per run Specification limits (λ): ±5% around the target content

Case 1: Content HPLC assay 14 Sending laboratory Receiving laboratory

Case 1: Content HPLC assay 15

16 Case 2: Bioassay Transfer between two QC labs of parallel line assay  Data taken from: 2012 PDA (Parenteral Drug Association) Technical report N°57 Analytical Method Validation and Transfer for Biotechnology products.  Design: 1 batch Sender: 4 runs, 2 replicates per run Receiver: 4 runs, 2 replicates per run Specification limits (λ): ±10% around the target content

17 Case 2: Bioassay Sending laboratory Receiving laboratory

Case 2: Bioassay 18

19 Case 3: Impurity HPLC assay Transfer between to QC labs of an HPLC assay to quantify an impurity in a drug product  Data taken from: Rozet et al, The transfer of a LC-UV method for the determination of fenofibrate and fenofibric acid in Lidoses: Use of total error as decision criterion, J. Pharm. Biomed. Anal. 42 (2006) 64–70.  Design: 1 batch Sender: 1 run 3 replicates Receiver: 5 runs, 3 replicates per run Specification limits (λ): <0.180 mg of impurity

20 Case 3: Impurity HPLC assay Sending laboratory Receiving laboratory

Case 3: Impurity HPLC assay 21

Case 3: Impurity HPLC assay Using informative prior for sending lab 22

Conclusions The proposed methodology allows to make a real fit for purpose decision about the acceptability of the Analytical Method Transfer Probability of success allows to make a risk based decision Applicable to any type of assays not only quantitative ones Easy extension to more complex designs (several batches, …) Allows to incorporate prior information 23

Contact: Eric Rozet, Statistician +32 (0)